Sunday, May 19, 2024
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.
Disclosures for additional planners can be found here.
Associate Professor of Neurology
Johns Hopkins University School of Medicine
Kennedy Krieger Institute
Baltimore, Maryland
Professor of Pediatrics, Neurology, Neurobiology, Genetics, and Psychology-Emeritus
Sarah Katherine Bateh Endowed Professorship for Rett Syndrome-Emeritus
University of Alabama at Birmingham
Birmingham, Alabama
Professor of Pediatrics
Division of Neurology, Pharmacology, and Special Education
Annette Schaffer Eskind Chair
Director
Vanderbilt Kennedy Center
Vanderbilt University Medical Center
Nashville, Tennessee
This activity has been peer reviewed and the reviewer has no relevant financial relationships.
This activity is intended for neurologists, pediatricians, primary care physicians (PCPs), and other clinicians who treat patients with Rett syndrome.
The goal of this activity is for learners to be better able to assess for and diagnose Rett syndrome and to increase their knowledge of clinical data on therapies being studied for the management of Rett syndrome.
Upon completion of this activity, participants will:
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.
Disclosures for additional planners can be found here.
Associate Professor of Neurology
Johns Hopkins University School of Medicine
Kennedy Krieger Institute
Baltimore, Maryland
Professor of Pediatrics, Neurology, Neurobiology, Genetics, and Psychology-Emeritus
Sarah Katherine Bateh Endowed Professorship for Rett Syndrome-Emeritus
University of Alabama at Birmingham
Birmingham, Alabama
Professor of Pediatrics
Division of Neurology, Pharmacology, and Special Education
Annette Schaffer Eskind Chair
Director
Vanderbilt Kennedy Center
Vanderbilt University Medical Center
Nashville, Tennessee
This activity has been peer reviewed and the reviewer has no relevant financial relationships.
Medscape, LLC designates this enduring material for a maximum of 1.0
AMA PRA Category 1 Credit(s)™
. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print
out the tally as well as the certificates from the CME/CE Tracker.
*The credit that you receive is based on your user profile.
CME / ABIM MOC Released: 3/7/2023
Valid for credit through: 3/7/2024, 11:59 PM EST
processing....
Since this program has been written, the FDA has approved trofinetide oral solution indicated for the treatment of Rett syndrome in adults and pediatric patients 2 years of age and older [Trofinetide [prescribing information] Approved 2023. Revised March 2023].
All sections of this activity are required for credit.
The goal of this activity is for learners to be better able to assess for and diagnose Rett syndrome and to increase their
knowledge of clinical data on therapies being studied for the management of Rett syndrome.
Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions
again after the activity will allow you to see what you learned and to compare your answers with those of your peers.
